Patent · US Active

Therapeutic agent for hematopoietic tumors

US8834876B2 · kind B2 · utility

4Cited by

9References

5Claims

0Family size

Assignee

CHUGAI SEIYAKU KABUSHIKI KAISHA · JP

Inventors

Masaaki Kosaka · Tokushima, JP
Shuji Ozaki · Tokushima, JP
Yuji Wakahara · Shizuoka, JP

Key dates

Filing date	Apr 13, 2011
Grant date	Sep 16, 2014
Priority date	—
Expiry date	Apr 13, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/732
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An inducing agent or enhancing agent, for the expression of HM1.24 antigen in hematopoietic tumor cells, comprising interferon α, interferon γ, or the IRF-2 protein as an active ingredient, as well as an antitumor agent for hematopoietic tumors which comprises a combination of said inducing agent or enhancing agent and an antibody against HM1.24.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.